419 completed, 72 unknown, 25 withdrawn, 21 recruiting. 149 Phase 3, 127 Phase 2, 119 Not applicable, 94 Phase 4, 42 Phase 1.
Follow Conjunctival Diseases: new trials by email Literature Review of Conjunctival Diseases trials Research Report on Conjunctival Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Video-Assisted Patient Education and Eye Fixation Training in Pterygium Surgery Video-Assisted Patient Education - Pterygium, Preoperative Anxiety | Not applicable | Not yet recruiting | Ataturk University | 152 | 2026-10-12 | 2026-10-05 |
| Subconjunctival Humira for Boston Keratoprosthesis Adalimumab Injection - Penetrating Keratoplasty, Multiple Graft Failure | Phase 1 | Not yet recruiting | Massachusetts Eye and Ear Infirmary | 8 | 2026-10-01 | 2026-08-31 |
| Investigating Nasal and Ocular Immune Response to Conjunctival Allergen Exposure Standardized Allergen Extract, Timothy Grass (Phleum pratense) - Allergic Rhinoconjunctivitis | Recruiting | Dr. Anne Ellis | 12 | 2026-09-01 | 2026-10-01 | |
| A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy Noninterventional - Conjunctivitis Allergic | Not yet recruiting | Regeneron Pharmaceuticals | 1500 | 2026-08-17 | 2026-07-17 | |
| A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy REGN-2Cat, Freneslerbart, Mevonlerbart - Allergic Conjunctivitis | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 570 | 2026-07-31 | 2026-08-12 |
| Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma Ivermectin - Survival of Flies Developing in Faecal Samples | Phase 4 | Not yet recruiting | London School of Hygiene and Tropical Medicine | 12 | 2026-07-01 | 2026-06-18 |
| Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis SUM-191, Placebo - Bacterial Conjunctivitis | Phase 1 / Phase 2 | Recruiting | Senju USA, Inc. | 426 | 2026-06-25 | 2026-06-30 |
| Daydrop® Triple Action for Allergic Eye Symptoms Eye Drops, Lubricant - Allergic Conjunctivitis of Both Eyes | Not applicable | Recruiting | i+Med S.Coop. | 49 | 2026-06-08 | 2026-09-04 |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED Cenegermin, Vehicle - Persistent Corneal Epithelial Defect | Phase 3 | Recruiting | Dompé Farmaceutici S.p.A | 150 | 2026-06-02 | 2026-10-07 |
| An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease DFL24498, Vehicle - Dry Eye Disease (DED) | Phase 2 | Recruiting | Dompé Farmaceutici S.p.A | 417 | 2026-05-12 | 2026-10-22 |
| A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis Slit Lamp Examination, Far Best Corrected Visual Acuity (BCVA), T1695 - Moderate to Severe Vernal Keratoconjunctivitis | Phase 2 | Recruiting | Laboratoires Thea | 120 | 2026-03-24 | 2026-04-22 |
| 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis 3% Diquafosol ophthalmic solution and 0.1% Cyclosporin A cationic ophthalmic emulsion, 0.1% Cyclosporin A cationic ophthalmic emulsion - Vernal Keratoconjunctivitis | Phase 3 | Recruiting | The University of Hong Kong | 94 | 2026-02-09 | 2026-04-30 |
| Comparing Two Surgical Methods to Prevent Pterygium Regrowth Conjunctival Rotational Flap, Conjunctival Autograft - Pterygium | Not applicable | Not yet recruiting | College of Physicians and Surgeons Pakistan | 342 | 2026-02-02 | 2025-12-11 |
| RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs) B-RAP, BLTR - Trachoma, Eye Diseases | Not applicable | Recruiting | University of North Carolina, Chapel Hill | 1000 | 2026-01-13 | 2026-04-13 |
| Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy REGN5713, REGN5715, Placebo - Allergic Conjunctivitis | Phase 3 | Terminated | Regeneron Pharmaceuticals | 24 | 2026-01-10 | 2026-09-01 |
| OJO-miR: microRNA Expression in Allergic Conjunctivitis. Conjunctivitis, Allergic | Active not recruiting | Instituto de Oftalmología Fundación Conde de Valenciana | 40 | 2026-01-05 | 2026-02-04 | |
| Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy Conjunctivitis, Allergic | Not yet recruiting | Instituto de Oftalmología Fundación Conde de Valenciana | 60 | 2026-01-01 | 2025-09-17 | |
| Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease Tofacitinib - Sjogren's Syndrome | Phase 2 | Recruiting | National Institute of Dental and Craniofacial Research (NIDCR) | 60 | 2025-12-18 | 2026-10-19 |
| Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects Allergic Rhinitis, Allergic Conjunctivitis | Not yet recruiting | Sven Schneider, MD | 152 | 2025-12-01 | 2025-05-07 |
Showing 20 of 586. Sign in to see all of them.
Conjunctivitis, Allergic (197) · Dry Eye Syndromes (105) · Pterygium (103) · Keratoconjunctivitis Sicca (85) · Conjunctivitis (72) · Trachoma (38) · Conjunctivitis, Bacterial (35) · Xerophthalmia (29) · Rhinitis, Allergic (28) · Hypersensitivity (23) · Corneal Diseases (19) · Sjogren's Syndrome (18) · Keratoconjunctivitis (17) · Pemphigoid, Benign Mucous Membrane (16)
Eye Diseases (574) · Conjunctivitis (357) · Immune System Diseases (245) · Hypersensitivity, Immediate (209) · Hypersensitivity (199) · Corneal Diseases (150) · Lacrimal Apparatus Diseases (135) · Infections (119) · Keratitis (102) · Eye Infections (96) · Keratoconjunctivitis (84) · Bacterial Infections and Mycoses (79) · Eye Infections, Bacterial (76) · Bacterial Infections (74)
Olopatadine Hydrochloride (31) · Azithromycin (24) · Ophthalmic Solutions (21) · Lubricant Eye Drops (18) · Loteprednol Etabonate (14) · Dexamethasone (12) · Cyclosporine (10) · Ketotifen (10) · Moxifloxacin (8) · bepotastine besilate (8) · Bevacizumab (7) · Cyclosporins (7) · alcaftadine (7) · Gatifloxacin (6) · Tacrolimus (6)
Alcon Research (30) · Bausch & Lomb Incorporated (24) · Allergan (18) · University of California, San Francisco (15) · Johns Hopkins University (10) · Regeneron Pharmaceuticals (10) · ORA, Inc. (9) · Vistakon Pharmaceuticals (9) · ALK-Abelló A/S (8) · Instituto de Oftalmología Fundación Conde de Valenciana (8) · Kissei Pharmaceutical Co., Ltd. (8) · Laboratorios Sophia S.A de C.V. (8) · Sun Yat-sen University (8) · Aldeyra Therapeutics, Inc. (7) · London School of Hygiene and Tropical Medicine (7)
United States (231) · China (36) · France (25) · Canada (20) · Germany (20) · Japan (19) · Italy (18) · Brazil (17) · Spain (17) · Mexico (16) · United Kingdom (16) · Taiwan (15) · Israel (13) · South Korea (12) · Ethiopia (11)
Gail Torkildsen, MD (6) · Brian Pall, OD, MS, FAAO (4) · Ching-Mao Chang, M.D., Ph.D. (4) · Gail L Torkildsen, MD (4) · Abhijit Narvekar, MS, MBBS (3) · Tarek Shazly, MD (3) · Tim McNamara, PharmD (3) · Tom Lietman, MD (3) · Allan Slomovic, MD (2) · Catherine Oldenburg, ScD, MPH (2)
PMID 10937547, PMID 24836393, PMID 25685162, PMID 31589610, PMID 19702708, PMID 20417925, PMID 21681652, PMID 22953007, PMID 22991696, PMID 23777441, PMID 25260889, PMID 25788949, PMID 26507708, PMID 27466061, PMID 28736342, PMID 30472141, PMID 10608921, PMID 11248822, PMID 12140209, PMID 12297693, PMID 12686302, PMID 12929992, PMID 14508260, PMID 14723108, PMID 15161841, PMID 15287367, PMID 15307986, PMID 15948994, PMID 15976462, PMID 16021174, PMID 16322853, PMID 16713521, PMID 16730066, PMID 16877412, PMID 16900272, PMID 16905024, PMID 16973668, PMID 17021840, PMID 17054241, PMID 17172891, PMID 17367957, PMID 17457187, PMID 17583820, PMID 17585003, PMID 17652708, PMID 18053915, PMID 18214740, PMID 18374301, PMID 18595980, PMID 18677274
2008 (2), 2016 (2), 2025 (2), 5UG1EY030833 (2), R01AI048789 (2), 1UG1EY028088 (1), 1UG1EY036891 (1), 2005 (1), 2018 (1), 2019 (1), K23EY019881 (1), R01EY012526 (1), R34EY017626 (1), U10EY022584 (1), U10EY023939 (1)